Get started
Author

Shilpi Mahajan

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
2019 · Federico Innocenti, Fang-Shu Ou, et al. · Journal of Clinical Oncology · 316
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types
2018 · Marie-Claire Wagle, Daniel Kirouac, et al. · npj Precision Oncology · 193
PDF
Phosphorylation and Dephosphorylation of Tyrosine 141 Regulate Stability and Degradation of INrf2
2008 · Abhinav K. Jain, Shilpi Mahajan, et al. · Journal of Biological Chemistry · 49
Enrichment of circulating tumor-derived extracellular vesicles from human plasma
2020 · Kathryn E. Yoh, Christopher J. Lowe, et al. · Journal of Immunological Methods · 39
Endothelin-Converting Enzyme-1 Actions Determine Differential Trafficking and Signaling of Corticotropin-Releasing Factor Receptor 1 at High Agonist Concentrations
2012 · Burcu Hasdemir, Shilpi Mahajan, et al. · Molecular Endocrinology · 32
Corticotropin-releasing Factor Receptor 2 Mediates Sex-Specific Cellular Stress Responses
2013 · Eric Kubat, Shilpi Mahajan, et al. · Molecular Medicine · 26
PDF
Urocortin 3 expression at baseline and during inflammation in the colon: Corticotropin releasing factor receptors cross-talk
2014 · Shilpi Mahajan, Min Liao, et al. · Peptides · 23
Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).
2017 · Federico Innocenti, Fang-Shu Ou, et al. · Journal of Clinical Oncology · 20
Actin cytoskeleton–dependent regulation of corticotropin-releasing factor receptor heteromers
2017 · Burcu Hasdemir, Shilpi Mahajan, et al. · Molecular Biology of the Cell · 18
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization
2022 · Shilpi Mahajan, Hui Zhao, et al. · Bioanalysis · 12
Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2. A novel mechanism in Nrf2 activation.
2016 · Abhinav K. Jain, Shilpi Mahajan, et al. · Journal of Biological Chemistry · 2
PDF
Utilization of a novel siRNA platform technology to target APOE in the brain for the treatment of Alzheimer’s Disease
2025 · Maxine R. Nelson, Marina Kovaliov, et al. · Alzheimer s & Dementia
PDF
Retraction: Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2. A NOVEL MECHANISM IN NRF2 ACTIVATION.
2017 · Abhinav K. Jain, Shilpi Mahajan, et al. · Journal of Biological Chemistry
PDF
Abstract 417: A novel predictive biomarker model for MEK sensitivity
2016 · Marie Wagle, Christiaan Klijn, et al. · Cancer Research
522 Sex-Specific Responses of the Corticotropin-Releasing Factor System in a Mouse Model of Inflammatory Bowel Disease
2015 · Burcu Hasdemir, Shilpi Mahajan, et al. · Gastroenterology
Mo1785 Urocortin 3 Expression At Baseline and During Inflammation in the Colon: Corticotropin Releasing Factor Receptors Cross-Talk
2014 · Shilpi Mahajan, Min Liao, et al. · Gastroenterology
Corticotropin‐releasing factor receptor crosstalk pivotal to ligand‐specific signaling and trafficking (795.3)
2014 · Shilpi Mahajan, Aditi Bhargava · The FASEB Journal
Sa1482 Acinar Cell Secretory Defects Due to Corticotropin-Releasing-Factor Receptor 2 (CRF2) Deficiency Leads to Exacerbation of Experimental Acute Pancreatitis: A Defect That is Rescued by Urocortin 1 Administration
2012 · Eric Kubat, Eileen F. Grady, et al. · Gastroenterology
Multiple Players Vying for One Target: Regulation of Differential Signaling Fate of Corticotropin‐releasing Factor Receptor 1 (CRF 1 )
2012 · Shilpi Mahajan, Burcu Hasdemir, et al. · The FASEB Journal
Corticotropin-releasing factor receptor 2 (CRF2) is essential for mediation of the urocortin1 anti-inflammatory response in experimental acute pancreatitis
2011 · Eric Kubat, Eileen Grady, et al. · Journal of the American College of Surgeons
De NovoExpression of Urocortin 1 (Ucn1) in Acinar Cells and Its Effect on Pancreatic Inflammation Is Mediated Via Corticotropin-Releasing Factor (CRF) Receptor 2
2011 · Eric Kubat, Eileen F Grady, et al. · The Endocrine Society eBooks
Works count: 23
Citation count: 731
H-index: 10
I10-index: 10
Year
Topic
Type